Home  |  Publications  |  Conferences   |  Join  |  Contact
                           
 
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics

Open Access
 
 
Meet Inspiring Speakers and Experts at our 1000+ Global Events
 

Upcoming Event

 

Editor-in-Chief

Editor in Chief Editor-in-Chief
Shufeng Zhou
Professor and Chair
Department of Pharmaceutical Sciences
University of South Florida
USA

Submit Manuscript


Submit manuscript at http://omicsonline.org/submitmanuscript-pharmacogenomics-pharmacoproteomics-open-access.php or send as an e-mail attachment to the Editorial Office at editor.jpp@omicsonline.org
 

About the Journal

Impact Factor: 1.69*

The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.

Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.

The Pharmacogenomics & Pharmacoproteomics Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Pharmacogenomics & Pharmacoproteomics journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Pharmacogenomics and Pharmacoproteomics Open Access Journals are freely accessible to everyone immediately after publication.

Submit Manuscript

Submit manuscript at http://editorialmanager.com/omicsgroup/ or send as an email attachment to the Editorial Office at editor.jpp@omicsonline.org

Pharmacogenomics and Personalized Medicine

Pharmacogenomics is part of a field called personalized medicine that aims to customize health care, with decisions and treatments tailored to each individual patient in every way possible.

Cancer Pharmacogenomics

Genetic variation influences the response of an individual to drug treatments. cancer, tumours may have specific disease-defining mutations, but a patient's germline genetic variation will also affect drug response. Cancer pharmacogenomics focus on the study of this genetic variation.

Pharmacogenomics Future Medicine

Pharmacogenetic approaches are widely expected to bring about a revolution in future medicine.

Pharmacogenomics Databases

Pharmacogenomics database is a resource for identifying all genetic variants that have been shown to affect drug response in patients.

Pharmacogenomics Companies and Market Analysis

Majority of pharmaceutical &medical agencies nowadays are actively involved in finding of genetic varioation and their affect on drug response to individual patient.

Pharmacogenomics Applications

There are several applications in the pharmaceutical industry for analysis in the area of pharmacogenetics / pharmacogenomics, like transcriptome analysis, or specific analysis of genes which are important for drug response and drug effect.

Pharmacogenomics for Patient Care

The study of the genetic basis for variation in drug response has provided important insights into a personalized approach to prescribing and dosing medications for patient care.

Pharmacogenetics

Pharmacogenetics explains about the inherited genetic differences in drug metabolic pathway which can affect individual response to drugs include therapeutic effect as well as adverse effects.

Pharmacoeconomics

Pharmacoeconomics is the study of scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another.

Pharmacoproteomics in Drug development

Pharmacoproteomics is the use of proteomic technologies in drug discovery and development. Along with pharmacogenomics and pharmacogenetics, pharmacoproteomics will play an important role in the development of personalized medicines.

Proteomics and Pharmacodynamics

Proteomics is an alternate methodology where all blood proteins modulated by disease or drug are used to resolve pharmacodynamic questions without the time, cost, and risk of developing an immunoassay.

Clinical Pharmacogenomics

Clinical pharmacogenomics quantitatively characterize the preliminary marker classifier performance like sensitivity, specificity, predictive values, reclassification, and explore the prognostic and predictive attributes of the marker.

Pharmacogenomic Biomarker

The rapid development of techniques in the area of genome analysis has facilitated identification of new pharmacogenomic biomarkers that can provide predictive tools for improved drug response and fewer adverse drug reactions

Gene polymorphism

Gene polymorphism is the simultaneous occurrence in the same locality of two or more discontinuous forms in such proportions that the rarest of them cannot be maintained just by recurrent mutation or immigration.

Epigenetics

Epigenetics is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself.

Translational Medicine

Translational medicine is a biomedical and public health research that plays main role to improve the health of individuals and the community by translating findings into diagnostic tools, medicines, procedures, policies and education.

Personalized Medicine

Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease.

Toxicogenomics

Toxicogenomics is a branch of science that deals with the collection, interpretation, and storage of information about gene and protein activity within particular cell or tissue of an organism in response to toxic substances.

Immune Disorders

Immune system begins to develop in the embryo and it localized In the several parts of the body. Immune cells develop in the primary organs like bone marrow and thymus. Immune responses occur in the secondary organs like spleen etc. Immune dosorders are nothing but a disease in which the body produces antibodies that attack its own tissues, leading to the deterioration and in some cases to the destruction of such tissue.

Metabolic Disorders

Metabolic disorder is a disorder or defect of metabolism, a physical condition in which there is a disturbance of normal functioning.

Drug Development

It is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

Individualized Medicine

It is a medical model that proposes the customization of healthcare - with medical decisions, practices, and/or products being tailored to the individual patient.

Genomic Targets

The integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination

Drug Dosage Formulations

A drug dose is the specific amount of medication to be taken at a given time. The dose and time to take the medication are written on a doctor’s prescription or recommended on the label of an over-the-counter medication

Drug Toxicity and Efficacy

Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug

OMICS International group is delighted to invite you to attend the 3rd International Conference on Genomics and Pharmacogenomics during september 21-23, 2015 San Antonio, USA.

 

*Unofficial 2014 Impact Factor was established by dividing the number of articles published in 2012 and 2013 with the number of times they are cited in 2014 based on Google search and the Scholar Citation Index database. If X is the total number of articles published in 2012 and 2013, and Y is the number of times these articles were cited in indexed journals during 2014 than, impact factor = X/Y

 

Recently published articles

 
 
 
Cross-Ethnic Distribution of Clinically Relevant Cyp2c19 Genotypes and Haplotypes

Narazah Mohd Yusoff*, Mohamed Saleem, Devaki Nagaya, Badrul Hisham Yahaya, Rasmaizatul Akma Rosdi, Nurfadhlina Moosa, Rusli Ismail and Tan Soo Choon

 
Personalized Medicine for Severe Asthma: How Far Have We Achieved?

Ting F Leung, FAAAAI, Man F Tang and Gary WK Wong

 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2015-16
 
Meet Inspiring Speakers and Experts at our 1000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@openaccessjournals.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@openaccessjournals.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@openaccessjournals.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@openaccessjournals.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

agrifoodaquavet@openaccessjournals.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@openaccessjournals.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@openaccessjournals.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@openaccessjournals.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@openaccessjournals.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@openaccessjournals.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@openaccessjournals.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@openaccessjournals.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@openaccessjournals.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@openaccessjournals.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@openaccessjournals.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@openaccessjournals.com

1-702-714-7001 Extn: 9042

 
© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version